| Fiscal Year End | Company Status | Exempt Flag |
| December 31 | Suspend | N |
|
|
|
|
|
| Incorporation Locations |
| Inc. Date | Expiry Date | Country | Region | Description |
| 15/Oct/2004 | | Canada | Ontario | |
|
|
| Exchange Filing Office |
| Location |
| NEX Service Office |
|
|  |
| Business Type(s) |
| Primary/Secondary | Business Type | Details |
| Primary
| Research And Development In The Life Sciences
| (not available)
|
|
|
| Securities |
| Symbol | Security Name | Market | Status |
| CLAS.H | Claritas Pharmaceuticals, Inc. | TSX Venture | SUSPEND |
|
|
| Name History | From | To |
| Claritas Pharmaceuticals, Inc. | 12/Apr/2021 | Present |
|
|
| Company Facts Reconciliation |
| Subject | Date Returned |
| Spring 2015 CFR | Not Received |
|
|
|
|
|
